Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma - A North American Brain Tumor Consortium Trial
Article
Chang, SM, Prados, MD, Yung, WKA et al. (2004). Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma - A North American Brain Tumor Consortium Trial
. CANCER, 100(8), 1712-1716. 10.1002/cncr.20157
Chang, SM, Prados, MD, Yung, WKA et al. (2004). Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma - A North American Brain Tumor Consortium Trial
. CANCER, 100(8), 1712-1716. 10.1002/cncr.20157